The Leipzig TAVI Registry

Helios Health Institute GmbH20,000 enrolled

Overview

A single-center registry including all patients treated with TAVI at the Heart Center, Leipzig, Germany

A single-center registry including all patients treated with transcatheter aortic valve implantation (TAVI) at the Heart Center, Leipzig, Germany. Patients undergo a routine clinical and echocardiographic follow-up schedule, including a long-term follow-up plan up to 10 years to assess valve durability.

Study Type

OBSERVATIONAL

Enrollment

20,000

Conditions

Aortic Valve Stenosis

Interventions

Transcatheter Aortic Valve ImplantationDEVICE

Interventional replacement of the aortic valve

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * All patients treated with TAVI Exclusion Criteria: * None

Locations (1)

Herzzentrum Leipzig

Leipzig, Germany

RECRUITING

Outcomes

Primary Outcomes

Mortality

Cardiovascular and not cardiovascular death 1. identify the current incidence of periprocedural complications. 2. identification of risk groups 3. description of the long-term outcome with special attention to the durability of the different prostheses

Time frame: Up to 10 years

Secondary Outcomes

Structural valve deterioration

Transposthetic mean pressure gradient ≥ 40mmHg and/or ≥20mmHg rise from baseline OR severe intraprosthetic aortic regurgitation

Time frame: Up to 10 years

Central Contacts

Mohamed Abdel-Wahab, MD

CONTACT

+49 341 865 1428 mohamed.bdel-wahab@medizin.uni-leipzig.de

Holger Thiele, MD

CONTACT

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.